AGC
AMGN icon

Aspen Grove Capital’s Amgen AMGN Stock Holding History

Aspen Grove Capital’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.05M Hold
2,888
– – 0.15% 75
2026
Q1 		$1.02M Hold
2,888
– – 0.2% 67
2025
Q4 		$946K Buy
2,888
+8
+0.3% +$2.54K 0.16% 70
2025
Q3 		$813K Sell
2,880
-104
-3% -$30.2K 0.14% 74
2025
Q2 		$833K Buy
2,984
+265
+10% +$75.1K 0.14% 79
2025
Q1 		$847K Buy
2,719
+106
+4% +$31.3K 0.16% 78
2024
Q4 		$681K Sell
2,613
-29
-1% -$8.6K 0.14% 85
2024
Q3 		$851K Hold
2,642
– – 0.19% 74
2024
Q2 		$825K Buy
2,642
+16
+0.6% +$4.7K 0.19% 71
2024
Q1 		$747K Buy
2,626
+11
+0.4% +$3.22K 0.21% 72
2023
Q4 		$750K Buy
2,615
+87
+3% +$23.7K 0.23% 73
2023
Q3 		$679K Buy
2,528
+93
+4% +$23.2K 0.25% 71
2023
Q2 		$541K Sell
2,435
-136
-5% -$31.6K 0.17% 107
2023
Q1 		$622K Buy
2,571
+57
+2% +$14K 0.27% 74
2022
Q4 		$660K Buy
+2,514
New +$674K 0.31% 67

Other funds holding AMGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Aspen Grove Capital's AMGN Position: Q2 2026 in Review

Aspen Grove Capital held its Amgen (AMGN) position steady in Q2 2026 at 2,888 shares worth $1.05M. The position accounts for 0.15% of the portfolio, ranked #75.

Aspen Grove Capital first reported a position in AMGN in Q4 2022 and has held it in 15 quarters since. 3,164 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Aspen Grove Capital held 2,888 shares of Amgen worth $1.05M as of Q2 2026.
  • Aspen Grove Capital left its Amgen share count unchanged in Q2 2026.
  • Amgen made up 0.15% of Aspen Grove Capital's portfolio in Q2 2026, its #75 holding.
  • Aspen Grove Capital first reported a position in Amgen in Q4 2022 and has held it in 15 quarters since.
  • 3,164 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Aspen Grove Capital's 13F filing for Q2 2026, filed 14 Aug 2026.